Consistent findings in lung cancer and glioblastoma indicate that AKR1B1 has been shown to promote EMT via activation of the RhoA–ROCK2 pathway, thereby enhancing migratory and invasive behavior [48]. Here, AKR1B1 is linked to lung cancer.